Mortality Rates from All Causes and Specific Conditions in Individuals Diagnosed with Bipolar II Disorder - Report - MDSpire

Mortality Rates from All Causes and Specific Conditions in Individuals Diagnosed with Bipolar II Disorder

  • By

  • Chih-Wei Hsu

  • Yang-Chieh Brian Chen

  • Edward Chia-Cheng Lai

  • Andrew A. Nierenberg

  • Michael Berk

  • Sheng-Yu Lee

  • Liang-Jen Wang

  • Mu-Hong Chen

  • Yao-Hsu Yang

  • Chih-Sung Liang

  • Andre F. Carvalho

  • April 7, 2026

  • 0 min

Share

Clinical Report: Mortality Rates in Individuals Diagnosed with Bipolar II Disorder

Overview

This study quantifies mortality rates in individuals with Bipolar II Disorder (BD-II) compared to matched controls, unaffected siblings, and those with Bipolar I Disorder (BD-I). Findings indicate that BD-II is associated with significantly elevated all-cause and cause-specific mortality, particularly from unnatural causes such as suicide.

Background

Bipolar II disorder is a serious mental health condition characterized by recurrent major depressive episodes and hypomanic episodes. Understanding the mortality risks associated with BD-II is crucial, as individuals with this disorder may experience substantial functional impairment and a reduced life expectancy. Previous studies have indicated that bipolar disorders are linked to increased mortality rates, but specific data on BD-II has been limited.

Data Highlights

Mortality TypeAdjusted Hazard Ratio (AHR)95% Confidence Interval (CI)
All-cause mortality1.621.47–1.78
Natural-cause mortality1.37N/A
Unnatural-cause mortality4.46N/A

Key Findings

  • BD-II is associated with a 62% increased risk of all-cause mortality compared to matched controls.
  • Natural-cause mortality is elevated in BD-II with an AHR of 1.37.
  • Unnatural-cause mortality is significantly higher in BD-II, with an AHR of 4.46, primarily due to suicide and unintentional injuries.
  • Within-family analyses suggest that the elevated risk of unnatural causes persists beyond shared familial factors.
  • Compared to BD-I, BD-II shows higher rates of both all-cause and natural-cause mortality.

Clinical Implications

Healthcare providers should be aware of the increased mortality risks associated with BD-II, particularly from unnatural causes. Regular monitoring and proactive management of physical health and suicide risk in patients with BD-II are essential to improve outcomes.

Conclusion

The findings underscore the need for heightened awareness and targeted interventions for individuals with Bipolar II Disorder to mitigate their elevated mortality risks.

References

  1. JAMA Network Open, 2026 -- All-Cause and Cause-Specific Mortality in Patients With Bipolar II Disorder
  2. BMC Psychiatry, 2025 -- Differences in event-related potentials between unipolar depression and bipolar II disorder during depressive episodes
  3. BMC Psychiatry, 2025 -- Neuroendocrine abnormalities as predictors of suicidal ideation in bipolar disorder patients during depressive episodes
  4. BMC Psychiatry, 2025 -- Investigating seasonal metabolic variations in bipolar disorder
  5. Bipolar disorder: assessment and management - NCBI Bookshelf
  6. BMC Psychiatry (Springer) — Comparative Analysis of Biochemical Metabolism and Cognitive Abilities in Bipolar I versus Bipolar II Disorder
  7. Bipolar disorder: assessment and management - NCBI Bookshelf
  8. All-Cause and Cause-Specific Mortality in Patients With Bipolar II Disorder | Bipolar and Related Disorders | JAMA Network Open | JAMA Network
  9. The efficacy of lithium in the treatment of suicidal ideation, behavior and suicide: An updated systematic review and meta-analysis of randomized controlled trials - ScienceDirect

Original Source(s)

Related Content